Harmony Biosciences Holdings, Inc.
HRMYNASDAQHealthcare● Active
$32.39
+$0.19(+0.59%)
Market Cap$1.9B
P/E Ratio—
52W High$40.87
52W Low$25.52
Harmony Biosciences Holdings, Inc. (HRMY) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · HRMY · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.78B | $0.47B | $0.35B | $0.32B | $0.23B |
| Net Receivables | $0.10B | $0.08B | $0.07B | $0.05B | $0.03B |
| Inventory | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Total Current Assets | $0.91B | $0.58B | $0.45B | $0.40B | $0.28B |
| PP&E Net | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.09B | $0.11B | $0.14B | $0.16B | $0.14B |
| Total Assets | $1.27B | $1.00B | $0.81B | $0.67B | $0.43B |
| Liabilities | |||||
| Short-Term Debt | $0.09B | $0.02B | $0.01B | $0.00B | $0.00B |
| Accounts Payable | $0.02B | $0.01B | $0.02B | $0.00B | $0.00B |
| Total Current Liabilities | $0.25B | $0.18B | $0.16B | $0.08B | $0.05B |
| Long-Term Debt | $0.15B | $0.16B | $0.18B | $0.19B | $0.19B |
| Total Liabilities | $0.40B | $0.34B | $0.34B | $0.27B | $0.25B |
| Stockholders Equity | |||||
| Retained Earnings | $0.16B | $0.00B | ($0.14B) | ($0.27B) | ($0.45B) |
| Total Stockholders Equity | $0.87B | $0.66B | $0.47B | $0.40B | $0.19B |
| Total Liab & Equity(computed) | $1.27B | $1.00B | $0.81B | $0.67B | $0.43B |
| Debt Summary | |||||
| Total Debt | $0.24B | $0.18B | $0.19B | $0.19B | $0.20B |
| Net Debt | ($0.51B) | ($0.27B) | ($0.12B) | ($0.05B) | ($0.04B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Harmony Biosciences Holdings, Inc. data
About Harmony Biosciences Holdings, Inc. (HRMY) Balance Sheet
Harmony Biosciences Holdings, Inc. (HRMY) balance sheet shows total assets of $1.27B with cash of $0.78B. Total liabilities are $0.40B, total debt $0.24B, and stockholders equity $0.87B.
Frequently asked questions
HRMY · 4 questionsHarmony Biosciences Holdings, Inc. has total debt of $0.24B with net debt of ($0.51B).
HRMY total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10